Using a pilot-centric, qualitative drug risk assessment model to identify opportunities for implementing pharmacogenetics
Abstract Background Risk assessment models are at the core of flight medicine, weighing both the impact of the flight environment on an aviator and the potential impact of medical events in aviators on flight operations. Pharmacogenetics is the application of a patient’s genetic information to reduc...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2022-09-01
|
| Series: | Future Journal of Pharmaceutical Sciences |
| Online Access: | https://doi.org/10.1186/s43094-022-00427-3 |